Abstract
Aim: To investigate whether it is safe for patients with Omicron variant infection to undergo surgery during the perioperative period. Methods: A total of 3,661 surgical patients were enrolled: 3,081 uninfected and 580 infected with the Omicron variant. Propensity score matching (PSM) at a 1:4 ratio was used to match groups based on 13 variables. The infected group (560 cases) was subdivided by time from infection to surgery (0-7, 8-14, 15-30, and >30 days). Multivariate logistic regression compared perioperative complications. Results: Only renal insufficiency (8-14 days) and anemia (>30 days) showed significant differences, both with lower odds in the infected subgroups. No significant differences were found in major complications like pneumonia, ICU transfer, or respiratory failure. Conclusion: Omicron infection does not significantly increase the risk of major perioperative complications and may not be a sufficient factor to postpone elective surgery.
Introduction
Early in the COVID-19 pandemic, undergoing surgery while infected (or shortly after recovery) was associated with high mortality and severe pulmonary complications. This led to global guidelines recommending a mandatory seven-week delay for elective procedures. However, the emergence of the Omicron variant, which is generally less pathogenic, and widespread vaccination have changed the risk landscape. This study investigates whether the "seven-week rule" remains necessary in the Omicron era or if it causes undue delays for essential surgeries.
Methods
This retrospective study utilized clinical data from the Army Medical Center of PLA (Daping Hospital) in Chongqing, China, covering the period from October 2022 to January 2023, when the Omicron-BA.5.2 variant was dominant.
The researchers matched 560 infected patients with 2,231 uninfected controls using PSM based on 13 variables, including age, gender, comorbidities (e.g., hypertension, diabetes), and surgery type. The infected cohort was stratified into four subgroups based on the interval between infection and surgery: 0–7 days, 8–14 days, 15–30 days, and >30 days.
Results
Multivariate logistic regression analysis demonstrated that Omicron infection did not significantly increase the risk of major respiratory or systemic complications across any of the time-based subgroups.
Key findings include:
- Major Complications: No significant differences were observed in postoperative ICU transfers, pneumonia, sepsis, respiratory failure, or deep vein thrombosis (DVT).
- Minor Statistical Deviations: Significant differences were noted only for renal insufficiency in the 8–14 day group (OR: 0.09) and anemia in the >30 day group (OR: 0.6), both indicating lower risk, though these were deemed clinically minor.
- Economic Impact: Medical expenses were significantly higher for infected patients, particularly those undergoing surgery within 0–7 days of infection.
Discussion and Conclusion
The findings suggest that the combination of Omicron’s lower virulence and high population vaccination rates (over 90% in this cohort) contributes to a safer perioperative profile than earlier variants. Consequently, Omicron infection alone may not justify the standard seven-week surgical delay, which can cause significant backlogs and delay essential care.
Limitations include the single-center retrospective design and the small size of the 8–14 day subgroup. Future multi-center prospective studies are needed to confirm these results as new sub-variants emerge. In conclusion, elective surgery appears safe for patients recently infected with Omicron, provided they are clinically stable.
Summary updated